Abstract
Disease and drug-related alterations in the brain membrane proteome are of particular interest for investigations into neuropsychiatric disorders. Despite decades of research into neurotransmitters and their receptors, our understanding of complex neuropsychiatric disorders has failed to advance substantially. Therefore, global membrane protein profiling studies that are non-hypothesis driven and exploratory are a complementary approach to elucidate the underlying pathomechanisms associated with psychiatric disorders. Although membrane proteins play critical roles in almost all cellular processes, their unique biochemical properties have challenged current quantitative proteomics approaches. The aim of the present review is to critically evaluate and discuss the use and applicability of current quantitative proteomic platforms, sample preparation methods and statistical tools in view of their application to membrane proteome analysis of brain tissue.
Keywords: Neuropsychiatric disorders, quantitative proteomics, membrane proteins, brain tissue
Current Proteomics
Title: Quantitative Proteomic Approaches to Investigate the Membrane Proteome in Neuropsychiatric Disorders
Volume: 4 Issue: 3
Author(s): Man K. Chan and Sabine Bahn
Affiliation:
Keywords: Neuropsychiatric disorders, quantitative proteomics, membrane proteins, brain tissue
Abstract: Disease and drug-related alterations in the brain membrane proteome are of particular interest for investigations into neuropsychiatric disorders. Despite decades of research into neurotransmitters and their receptors, our understanding of complex neuropsychiatric disorders has failed to advance substantially. Therefore, global membrane protein profiling studies that are non-hypothesis driven and exploratory are a complementary approach to elucidate the underlying pathomechanisms associated with psychiatric disorders. Although membrane proteins play critical roles in almost all cellular processes, their unique biochemical properties have challenged current quantitative proteomics approaches. The aim of the present review is to critically evaluate and discuss the use and applicability of current quantitative proteomic platforms, sample preparation methods and statistical tools in view of their application to membrane proteome analysis of brain tissue.
Export Options
About this article
Cite this article as:
Chan K. Man and Bahn Sabine, Quantitative Proteomic Approaches to Investigate the Membrane Proteome in Neuropsychiatric Disorders, Current Proteomics 2007; 4 (3) . https://dx.doi.org/10.2174/157016407783221321
DOI https://dx.doi.org/10.2174/157016407783221321 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
Call for Papers in Thematic Issues
Mass spectrometry data acquisition and analysis for proteomics
The Thematic Issue on "Mass spectrometry data acquisition and analysis for proteomics" aims to explore the latest advancements and challenges in the field of proteomics through the lens of mass spectrometry. Proteomics, the large-scale study of proteins and their functions, plays a crucial role in understanding various biological processes and ...read more
Peptides: State-of-Art and Commercialisation Hurdles
The Editors of the Current Proteomics (CP) journal are highly privileged to welcome scientists to submit their scientific research and review articles to be considered for publication in the upcoming thematic issue. The topics should cover various aspects of peptides in regard to their synthetic methodologies, formulation approaches, pharmacological challenges, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Policies to Prevent Tobacco Use and Exposure in Children, a Global Perspective
Current Pediatric Reviews Infectious Agents and Neurodegenerative Diseases: Exploring the Links
Current Topics in Medicinal Chemistry Hotspot Mutations in DICER1 Causing GLOW Syndrome-Associated Macrocephaly <i>via</i> Modulation of Specific microRNA Populations Result in the Activation of PI3K/ATK/mTOR Signaling
MicroRNA Pyridoxal 5-Phosphate Enzymes as Targets for Therapeutic Agents
Current Medicinal Chemistry Antioxidant Activity of Thio-Schiff Bases
Letters in Drug Design & Discovery Pharmacogenetics in Methadone Therapy
Current Pharmacogenomics and Personalized Medicine Formulation Development and Evaluation of Novel Vesicular Carrier for Enhancement of Bioavailability of Poorly Soluble Drug
Pharmaceutical Nanotechnology The Mechanism of Plasmid Curing in Bacteria
Current Drug Targets Child Abuse and Neglect and its Psycho-Physical and Social Consequences: A Review of the Literature
Current Pediatric Reviews Genetic Polymorphism of the Flavin-Containing Monooxygenase 3 (FMO3) Associated with Trimethylaminuria (Fish Odor Syndrome): Observations from Japanese Patients
Current Drug Metabolism Pyroglutamate-Modified Amyloid Beta Peptides: Emerging Targets for Alzheimer´s Disease Immunotherapy
Current Neuropharmacology Medicinal Chemistry of P2X Receptors: Agonists and Orthosteric Antagonists
Current Medicinal Chemistry Near-Infrared Dyes: Probe Development and Applications in Optical Molecular Imaging
Current Organic Synthesis Pre-Clinical Evidence that Corticotropin-Releasing Factor (CRF) Receptor Antagonists are Promising Targets for Pharmacological Treatment of Alcoholism
CNS & Neurological Disorders - Drug Targets Proteins Commonly Linked to Autism Spectrum Disorder and Alzheimer's Disease
Current Protein & Peptide Science Thrombolytic Agents for Acute Ischaemic Stroke Treatment: The Past, Present and Future
CNS & Neurological Disorders - Drug Targets Therapeutic Role of Zonisamide in Neuropsychiatric Disorders
Mini-Reviews in Medicinal Chemistry Clinical and Serological Biomarkers of Treatment’s Response in Multiple Sclerosis Patients Treated Continuously with Interferonβ-1b for More than a Decade
CNS & Neurological Disorders - Drug Targets Stem Cell-Based Immunomodulation in Type 1 Diabetes: Beyond the Regenerative Approach
Current Pharmaceutical Design Sialic Acid Recognition of the Pandemic Influenza 2009 H1N1 Virus: Binding Mechanism Between Human Receptor and Influenza Hemagglutinin
Protein & Peptide Letters